Results 101 to 110 of about 28,888 (167)

Anti-inflammatory effect of lamivudine on ulcerative colitis. [PDF]

Biochem Biophys Rep
Chen X, Wang H, Liu Y, Zhang W, Song Z.
europepmc   +1 more source

Long-Term Effectiveness and Tolerability of Dolutegravir/Lamivudine in Korea: A 3-Year Follow Up Study. [PDF]

Infect Chemother
Seong JE, Ahn SM, Han M, Lee YS, Lee JA, Ahn JY, Jeong SJ, Ku NS, Choi JY, Yeom JS, Kim JH.   +10 more
europepmc   +1 more source

A systematic review and meta-analysis of hepatitis B virus drug resistance and escape mutations in low- and middle-income countries. [PDF]

Ther Adv Infect Dis
Asamoah EME, Asantewaa AA, Yartey SN, Nii-Trebi NI, Donkor ES.   +4 more
europepmc   +1 more source

Post-market surveillance of antiretroviral drug quality in Tanzania in the context of rising HIV drug resistance. [PDF]

Sci Rep
Mlugu EM, Mhagama JB, Sangeda RZ, Kunambi PP, Samwel T, Shiletiwa N, Gotora G, Chambiri SM, Matiko D, Hipolite D, Mwalwisi YH, Fimbo AM.   +11 more
europepmc   +1 more source

Antiretroviral Treatment Switch Among Treatment-Experienced People with HIV. [PDF]

J Health Econ Outcomes Res
Chastek B, Mordi U, Christoph MJ, Le LB, Lim T, Majethia S, Trom C, Cohen J.   +7 more
europepmc   +1 more source

Efficacy of Dolutegravir Plus Lamivudine in People With TB/HIV Co-Infection Using a Rifampicin or Rifabutin-Based Regimen: A Retrospective Observational Case Series. [PDF]

Immun Inflamm Dis
He J, He X, Xie X, Fu Y, Luo X, Peng Y, Xu B, Long H.   +7 more
europepmc   +1 more source

Baseline Data on Viral Suppression, Treatment Adherence and Mental Health in Peripartum Girls and Young Women With HIV in Zimbabwe. [PDF]

J Int AIDS Soc
Chawana-Mutingwende TD, Ngara B, Mudadi LS, Tauya TT, Sibanda M, Mutambanengwe-Jacob M, Andifasi P, Malunda B, Chidemo T, Mapfunde A, Nyakudya S, Mufumisi AZ, Chirenda TH, Chitambo T, Nderecha WTS, Murandu C, Gwande M, Muringayi K, Micah Bongo R, Okochi H, Kuncze K, Mushavi A, Willis N, Webb K, Gandhi M, Stranix-Chibanda L.   +25 more
europepmc   +1 more source

HIV-1 Resistance to Dolutegravir in Benin: The Need to Improve and Strengthen Therapeutic Patient Education Strategies to Achieve the Third Objective 95 of UNAIDS 95-95-95 Target. [PDF]

Case Rep Infect Dis
Tchiakpe E, Diop-Ndiaye H, Osawe S, Toure-Kane C, Yessoufou A.   +4 more
europepmc   +1 more source

Bis-prodrug cryopreserved lipid nanoparticles with enzymatically triggered release. [PDF]

Nanoscale Adv
Hogarth C, Arnold K, Elkateb H, Rannard S, McDonald TO.   +4 more
europepmc   +1 more source

Exploratory analysis of lamivudine legacy and clonal selection of HBs truncation mutants in HBV-related hepatocellular carcinoma. [PDF]

Infect Agent Cancer
Chu YD, Ho PH, Hsu CW, Chiou CY, Lai MW, Yeh CT.   +5 more
europepmc   +1 more source